Franklin Resources
CRDF icon

Franklin Resources’s Cardiff Oncology CRDF Stock Holding History

Franklin Resources’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Hold
1,205,803
– – ﹤0.01% 2103
2026
Q1 		$1.95M Hold
1,205,803
– – ﹤0.01% 1920
2025
Q4 		$3.39M Buy
+1,205,803
New +$2.8M ﹤0.01% 1580
2021
Q3 		– Sell
-618,600
Closed -$4.11M – 2461
2021
Q2 		$4.11M Sell
618,600
-21
-0% -$178 ﹤0.01% 1185
2021
Q1 		$5.73M Hold
618,621
– – ﹤0.01% 1080
2020
Q4 		$11.1M Buy
+618,621
New +$10.9M ﹤0.01% 937

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Franklin Resources's CRDF Position: Q2 2026 in Review

Franklin Resources held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 1,205,803 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

Franklin Resources first reported a position in CRDF in Q4 2020 and has held it in 6 quarters since. The position peaked at $11.1M in Q4 2020. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Franklin Resources held 1,205,803 shares of Cardiff Oncology worth $1.57M as of Q2 2026.
  • Franklin Resources left its Cardiff Oncology share count unchanged in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2103 holding.
  • Franklin Resources first reported a position in Cardiff Oncology in Q4 2020 and has held it in 6 quarters since.
  • Franklin Resources's Cardiff Oncology position peaked at $11.1M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.